{"id":5457,"date":"2022-03-21T09:56:03","date_gmt":"2022-03-21T13:56:03","guid":{"rendered":"https:\/\/spharm-inc.com\/wp2021\/?p=5457"},"modified":"2025-03-28T16:40:39","modified_gmt":"2025-03-28T20:40:39","slug":"quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments","status":"publish","type":"post","link":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/","title":{"rendered":"Quel type de protection commerciale est en vigueur au Canada pour les nouveaux m\u00e9dicaments?"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Quel type de protection commerciale est en vigueur au Canada pour les nouveaux m\u00e9dicaments?<\/h1>

\u00a0<\/strong><\/span><\/p>

QUEL TYPE DE PROTECTION DES DONN\u00c9ES EST EN VIGUEUR AU CANADA ET COMMENT CELA S\u2019APPLIQUE-T-IL?<\/strong><\/span><\/p>

Tous les m\u00e9dicaments contenant un nouvel ingr\u00e9dient actif sont admissibles \u00e0 une p\u00e9riode d\u2019exclusivit\u00e9 de huit ans sur le march\u00e9. Si le produit est destin\u00e9 \u00e0 une population p\u00e9diatrique, une extension suppl\u00e9mentaire de six mois peut s\u2019appliquer si les donn\u00e9es p\u00e9diatriques acceptables sont soumises au cours des cinq premi\u00e8res ann\u00e9es de la p\u00e9riode de huit ans. Sant\u00e9 Canada effectuera une \u00e9valuation pr\u00e9liminaire pendant que le m\u00e9dicament fait l\u2019objet d\u2019un examen (PDN) et le promoteur sera avis\u00e9 du r\u00e9sultat.<\/p>

Par cons\u00e9quent, un fabricant d\u00e9sirant effectuer une entr\u00e9e subs\u00e9quente sur le march\u00e9 n\u2019est pas autoris\u00e9 \u00e0 d\u00e9poser une demande pour un m\u00e9dicament g\u00e9n\u00e9rique au cours des six premi\u00e8res ann\u00e9es de la p\u00e9riode de huit ans. Pour les produits avec des brevets \u00e9ligibles, la soumission des formulaires de brevet dans les PDN et SPDN est essentielle pour \u00e9viter la perte des droits d\u2019exclusivit\u00e9 et l\u2019entr\u00e9e de g\u00e9n\u00e9riques sur le march\u00e9 plus t\u00f4t que ce que ne permet le march\u00e9.

<\/p>


Pour toute question sur le processus canadien d\u2019examen et de r\u00e9glementation des m\u00e9dicaments qui n\u2019est pas couverte dans cette section, n\u2019h\u00e9sitez pas \u00e0 communiquer directement avec nous<\/a>.<\/h3>
\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Quel type de protection commerciale est en vigueur au Canada pour les nouveaux m\u00e9dicaments? \u00a0 QUEL TYPE DE PROTECTION DES DONN\u00c9ES EST EN VIGUEUR AU CANADA ET COMMENT CELA S\u2019APPLIQUE-T-IL? Tous les m\u00e9dicaments contenant un nouvel ingr\u00e9dient actif sont admissibles \u00e0 une p\u00e9riode d\u2019exclusivit\u00e9 de huit ans sur le march\u00e9. Si le produit est destin\u00e9 […]<\/p>\n","protected":false},"author":3,"featured_media":6466,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-5457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nQuelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?<\/title>\n<meta name=\"description\" content=\"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?\" \/>\n<meta property=\"og:description\" content=\"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/\" \/>\n<meta property=\"og:site_name\" content=\"Canada's Drug & Health Product Regulatory Experts\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-21T13:56:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-28T20:40:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1640\" \/>\n\t<meta property=\"og:image:height\" content=\"924\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"SPharm Canada\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@2021-08-24 16:28:44\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"SPharm Canada\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/\",\"url\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/\",\"name\":\"Quelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?\",\"isPartOf\":{\"@id\":\"https:\/\/spharm-inc.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg\",\"datePublished\":\"2022-03-21T13:56:03+00:00\",\"dateModified\":\"2025-03-28T20:40:39+00:00\",\"author\":{\"@id\":\"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/a37a21d64482aea4348baedfe3ed845a\"},\"description\":\"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.\",\"breadcrumb\":{\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage\",\"url\":\"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg\",\"contentUrl\":\"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg\",\"width\":1640,\"height\":924},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/spharm-inc.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quel type de protection commerciale est en vigueur au Canada pour les nouveaux m\u00e9dicaments?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/#website\",\"url\":\"https:\/\/spharm-inc.com\/fr\/\",\"name\":\"Canada's Drug & Health Product Regulatory Experts\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/spharm-inc.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/a37a21d64482aea4348baedfe3ed845a\",\"name\":\"SPharm Canada\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6bd2a74a6f9b867851a1cfe6a675fbe0b0734774c6762861ddb4527adaf7e7c3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6bd2a74a6f9b867851a1cfe6a675fbe0b0734774c6762861ddb4527adaf7e7c3?s=96&d=mm&r=g\",\"caption\":\"SPharm Canada\"},\"description\":\"With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada. Avec un quart de si\u00e8cle de r\u00e9sultats et de succ\u00e8s constants , SPharm est devenue une entreprise de services de r\u00e9f\u00e9rence au Canada en strat\u00e9gie de d\u00e9veloppement de m\u00e9dicaments et affaires r\u00e9glementaires. Des compagnies pharmaceutiques \u00e0 travers le monde comptent sur SPharm pour faciliter le processus d'homologation de leurs m\u00e9dicaments (et autres produits de sant\u00e9) au Canada.\",\"sameAs\":[\"https:\/\/x.com\/2021-08-24 16:28:44\"],\"url\":\"https:\/\/spharm-inc.com\/fr\/author\/spharm-canada\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?","description":"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/","og_locale":"fr_FR","og_type":"article","og_title":"Quelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?","og_description":"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.","og_url":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/","og_site_name":"Canada's Drug & Health Product Regulatory Experts","article_published_time":"2022-03-21T13:56:03+00:00","article_modified_time":"2025-03-28T20:40:39+00:00","og_image":[{"width":1640,"height":924,"url":"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg","type":"image\/jpeg"}],"author":"SPharm Canada","twitter_card":"summary_large_image","twitter_creator":"@2021-08-24 16:28:44","twitter_misc":{"\u00c9crit par":"SPharm Canada","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/","url":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/","name":"Quelle protection commerciale pour nouveaux m\u00e9dicaments au Canada ?","isPartOf":{"@id":"https:\/\/spharm-inc.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage"},"image":{"@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage"},"thumbnailUrl":"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg","datePublished":"2022-03-21T13:56:03+00:00","dateModified":"2025-03-28T20:40:39+00:00","author":{"@id":"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/a37a21d64482aea4348baedfe3ed845a"},"description":"Explorez les protections commerciales canadiennes en vigueur, incluant brevets et exclusivit\u00e9s, d\u00e9di\u00e9es aux nouveaux m\u00e9dicaments.","breadcrumb":{"@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#primaryimage","url":"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg","contentUrl":"https:\/\/spharm-inc.com\/wp-content\/uploads\/Quel-type-de-protection-commerciale-est-en-vigueur-au-Canada-pour-les-nouveaux-medicaments.jpg","width":1640,"height":924},{"@type":"BreadcrumbList","@id":"https:\/\/spharm-inc.com\/fr\/quel-type-de-protection-commerciale-est-en-vigueur-au-canada-pour-les-nouveaux-medicaments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/spharm-inc.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Quel type de protection commerciale est en vigueur au Canada pour les nouveaux m\u00e9dicaments?"}]},{"@type":"WebSite","@id":"https:\/\/spharm-inc.com\/fr\/#website","url":"https:\/\/spharm-inc.com\/fr\/","name":"Canada's Drug & Health Product Regulatory Experts","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/spharm-inc.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/a37a21d64482aea4348baedfe3ed845a","name":"SPharm Canada","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/spharm-inc.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6bd2a74a6f9b867851a1cfe6a675fbe0b0734774c6762861ddb4527adaf7e7c3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6bd2a74a6f9b867851a1cfe6a675fbe0b0734774c6762861ddb4527adaf7e7c3?s=96&d=mm&r=g","caption":"SPharm Canada"},"description":"With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada. Avec un quart de si\u00e8cle de r\u00e9sultats et de succ\u00e8s constants , SPharm est devenue une entreprise de services de r\u00e9f\u00e9rence au Canada en strat\u00e9gie de d\u00e9veloppement de m\u00e9dicaments et affaires r\u00e9glementaires. Des compagnies pharmaceutiques \u00e0 travers le monde comptent sur SPharm pour faciliter le processus d'homologation de leurs m\u00e9dicaments (et autres produits de sant\u00e9) au Canada.","sameAs":["https:\/\/x.com\/2021-08-24 16:28:44"],"url":"https:\/\/spharm-inc.com\/fr\/author\/spharm-canada\/"}]}},"_links":{"self":[{"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/posts\/5457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/comments?post=5457"}],"version-history":[{"count":1,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/posts\/5457\/revisions"}],"predecessor-version":[{"id":27844,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/posts\/5457\/revisions\/27844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/media\/6466"}],"wp:attachment":[{"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/media?parent=5457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/categories?post=5457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/spharm-inc.com\/fr\/wp-json\/wp\/v2\/tags?post=5457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}